Christina Karavasili1, Emmanuel Panteris2, Ioannis S Vizirianakis3, Sotirios Koutsopoulos4, Dimitrios G Fatouros5. 1. School of Pharmacy, Department of Pharmaceutical Technology, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece. 2. Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece. 3. School of Pharmacy, Laboratory of Pharmacology, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece. 4. Center for Biomedical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA. 5. School of Pharmacy, Department of Pharmaceutical Technology, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece. dfatouro@pharm.auth.gr.
Abstract
PURPOSE: Localized chemotherapy has gained significant impetus for the management of malignant brain tumors. In the present study, we appraised the versatility of an in-situ gel forming self-assembling peptide, ac-(RADA)4-CONH2, as a biocompatible delivery depot of the chemotherapeutic drug doxorubicin (DOX) and the anticancer agent curcumin (CUR), respectively. METHODS: The morphology and mechanical properties of ac-(RADA)4-CONH2 were assessed with scanning electron microscopy (SEM) and rheological studies. The in vitro drug release from ac-(RADA)4-CONH2 was monitored in phosphate-buffered saline pH 7.4. Distribution of the fluorescent actives within the peptide matrix was visualized with confocal laser scanning microscopy (CLSM). The in vitro biological performance of the ac-(RADA)4-CONH2-DOX and ac-(RADA)4-CONH2-CUR was evaluated on the human glioblastoma U-87 MG cell line. RESULTS: SEM studies revealed that the ac-(RADA)4-CONH2 hydrogel contains an entangled nanofiber network. Rheology studies showed that the more hydrophobic CUR resulted in a stiffer hydrogel compared with ac-(RADA)4-CONH2 and ac-(RADA)4-CONH2-DOX, due to the interaction of CUR with the hydrophobic domains of the peptide nanofibers as confirmed by CLSM. In vitro release studies showed a complete DOX release from ac-(RADA)4-CONH2 within 4 days and a prolonged release for ac-(RADA)4-CONH2-CUR over 20 days. An increased cellular uptake and a higher cytotoxic effect were observed for ac-(RADA)4-CONH2-DOX, compared with DOX solution. Higher levels of early apoptosis were observed for the cells treated with the ac-(RADA)4-CONH2-CUR, compared to CUR solution. CONCLUSIONS: The current findings highlight the potential utility of the in-situ depot forming ac-(RADA)4-CONH2 hydrogel for the local delivery of both water soluble and insoluble chemotherapeutic drugs.
PURPOSE: Localized chemotherapy has gained significant impetus for the management of malignant brain tumors. In the present study, we appraised the versatility of an in-situ gel forming self-assembling peptide, ac-(RADA)4-CONH2, as a biocompatible delivery depot of the chemotherapeutic drug doxorubicin (DOX) and the anticancer agent curcumin (CUR), respectively. METHODS: The morphology and mechanical properties of ac-(RADA)4-CONH2 were assessed with scanning electron microscopy (SEM) and rheological studies. The in vitro drug release from ac-(RADA)4-CONH2 was monitored in phosphate-buffered saline pH 7.4. Distribution of the fluorescent actives within the peptide matrix was visualized with confocal laser scanning microscopy (CLSM). The in vitro biological performance of the ac-(RADA)4-CONH2-DOX and ac-(RADA)4-CONH2-CUR was evaluated on the humanglioblastoma U-87 MG cell line. RESULTS: SEM studies revealed that the ac-(RADA)4-CONH2 hydrogel contains an entangled nanofiber network. Rheology studies showed that the more hydrophobic CUR resulted in a stiffer hydrogel compared with ac-(RADA)4-CONH2 and ac-(RADA)4-CONH2-DOX, due to the interaction of CUR with the hydrophobic domains of the peptide nanofibers as confirmed by CLSM. In vitro release studies showed a complete DOX release from ac-(RADA)4-CONH2 within 4 days and a prolonged release for ac-(RADA)4-CONH2-CUR over 20 days. An increased cellular uptake and a higher cytotoxic effect were observed for ac-(RADA)4-CONH2-DOX, compared with DOX solution. Higher levels of early apoptosis were observed for the cells treated with the ac-(RADA)4-CONH2-CUR, compared to CUR solution. CONCLUSIONS: The current findings highlight the potential utility of the in-situ depot forming ac-(RADA)4-CONH2 hydrogel for the local delivery of both water soluble and insoluble chemotherapeutic drugs.
Entities:
Keywords:
cancer treatment; curcumin; doxorubicin; drug delivery; self-assembly
Authors: Handan Acar; Samanvaya Srivastava; Eun Ji Chung; Mathew R Schnorenberg; John C Barrett; James L LaBelle; Matthew Tirrell Journal: Adv Drug Deliv Rev Date: 2016-08-14 Impact factor: 15.470
Authors: Thibaut Fourniols; Luc D Randolph; Aurélie Staub; Kevin Vanvarenberg; Julian G Leprince; Véronique Préat; Anne des Rieux; Fabienne Danhier Journal: J Control Release Date: 2015-05-15 Impact factor: 9.776
Authors: Paul H Liebesny; Sangwon Byun; Han-Hwa Hung; James R Pancoast; Keri A Mroszczyk; Whitney T Young; Richard T Lee; David D Frisbie; John D Kisiday; Alan J Grodzinsky Journal: Tissue Eng Part A Date: 2016-06-28 Impact factor: 3.845
Authors: Ching-Ting Tsao; Forrest M Kievit; Ali Ravanpay; Ariane E Erickson; Michael C Jensen; Richard G Ellenbogen; Miqin Zhang Journal: Biomacromolecules Date: 2014-06-25 Impact factor: 6.988
Authors: Nikoleta F Theodoroula; Christina Karavasili; Manos C Vlasiou; Alexandra Primikyri; Christia Nicolaou; Alexandra V Chatzikonstantinou; Aikaterini-Theodora Chatzitaki; Christos Petrou; Nikolaos Bouropoulos; Constantinos K Zacharis; Eleftheria Galatou; Yiannis Sarigiannis; Dimitrios G Fatouros; Ioannis S Vizirianakis Journal: Pharmaceutics Date: 2022-01-06 Impact factor: 6.321